CIANCIOLO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 4.399
AS - Asia 3.581
EU - Europa 3.296
AF - Africa 270
SA - Sud America 193
Continente sconosciuto - Info sul continente non disponibili 184
OC - Oceania 6
Totale 11.929
Nazione #
US - Stati Uniti d'America 4.331
VN - Vietnam 1.094
SG - Singapore 1.031
CN - Cina 777
IT - Italia 730
GB - Regno Unito 682
DE - Germania 572
SE - Svezia 271
HK - Hong Kong 240
FR - Francia 183
UA - Ucraina 167
IN - India 162
FI - Finlandia 160
RU - Federazione Russa 137
BR - Brasile 128
IE - Irlanda 111
TG - Togo 95
NL - Olanda 87
ZA - Sudafrica 72
JP - Giappone 56
EE - Estonia 50
BG - Bulgaria 42
JO - Giordania 42
SC - Seychelles 40
CA - Canada 38
BE - Belgio 35
KR - Corea 26
AR - Argentina 25
BD - Bangladesh 24
CI - Costa d'Avorio 22
PH - Filippine 20
NG - Nigeria 18
TH - Thailandia 17
CH - Svizzera 14
IQ - Iraq 14
IR - Iran 14
EC - Ecuador 13
MX - Messico 13
PL - Polonia 12
TR - Turchia 11
TW - Taiwan 10
AT - Austria 9
CO - Colombia 9
ES - Italia 9
CL - Cile 7
PK - Pakistan 7
UZ - Uzbekistan 7
DZ - Algeria 6
ID - Indonesia 6
SA - Arabia Saudita 6
AU - Australia 5
GR - Grecia 5
HN - Honduras 5
KE - Kenya 4
NP - Nepal 4
PT - Portogallo 4
PY - Paraguay 4
RO - Romania 4
VE - Venezuela 4
EG - Egitto 3
JM - Giamaica 3
LT - Lituania 3
MA - Marocco 3
TT - Trinidad e Tobago 3
AL - Albania 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
LB - Libano 2
MY - Malesia 2
RS - Serbia 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
ET - Etiopia 1
FJ - Figi 1
GH - Ghana 1
GL - Groenlandia 1
IL - Israele 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
SR - Suriname 1
SX - ???statistics.table.value.countryCode.SX??? 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
TN - Tunisia 1
UG - Uganda 1
UY - Uruguay 1
Totale 11.749
Città #
Singapore 775
Southend 568
Ashburn 478
Fairfield 371
Chandler 354
Ann Arbor 287
Hong Kong 235
San Jose 204
Munich 201
Dong Ket 192
Wilmington 191
Ho Chi Minh City 186
Houston 183
Hanoi 177
Santa Clara 166
Woodbridge 161
Helsinki 144
Seattle 137
Princeton 129
Cambridge 120
Beijing 118
Jacksonville 117
Dublin 111
Lomé 95
Council Bluffs 87
Boardman 82
Nanjing 70
Bologna 65
Westminster 61
Padova 60
Lauterbourg 51
Los Angeles 50
Milan 48
Turin 47
Berlin 46
Tokyo 46
Amman 42
Frankfurt am Main 42
Sofia 40
Dearborn 35
Jinan 35
Brussels 34
New York 34
Buffalo 33
Florence 31
Changsha 29
Hefei 29
Rome 28
Dallas 27
Shenyang 27
Bremen 26
Johannesburg 26
São Paulo 25
Abidjan 22
Da Nang 22
Medford 22
Nanchang 22
Tianjin 21
Hebei 20
Mülheim 20
Saint Petersburg 20
Guangzhou 18
Haiphong 18
Falkenstein 17
Phoenix 17
Abeokuta 16
Falls Church 16
Redondo Beach 16
Redwood City 16
Hyderabad 15
London 15
Toronto 15
Zhengzhou 15
Shanghai 14
Hangzhou 12
Mahé 12
Mountain View 12
San Diego 12
Amsterdam 11
Brooklyn 10
Can Tho 10
Fuzhou 10
Orem 10
Pune 10
Seoul 10
Des Moines 9
Hải Dương 9
Jiaxing 9
Atlanta 8
Chicago 8
Leawood 8
Montreal 8
Norwalk 8
San Francisco 8
Guayaquil 7
Ningbo 7
Rio de Janeiro 7
Taiyuan 7
Tashkent 7
Turku 7
Totale 7.569
Nome #
La sindrome delle gambe senza riposo in dialisi. Ruolo dell'infiammazione cronica 497
Molecular Adsorbent Recirculating System (MARS) application in liver failure: Clinical and hemodepurative results in 22 patients 409
Multislice spiral computed tomography (MSCT) for coronary artery calcifications in hemodialysis patients 298
Accesso vascolare e infiammazione: fistola arterovenosa (FAV) vs protesi in PTFE vs cateteri venosi centrali a permanenza (TCC) 276
5-Methyltetrahydrofolate Administration Is Associated with Prolonged Survival and Reduced Inflammation in ESRD Patients 273
Cardiovascular Disease in Kidney Transplant Recipients: The Prognostic Value of Inflammatory Cytokine Genotypes. 269
Effects of unfractioned heparin and low-molecular-weight heparin on osteoprotegerin and RANKL plasma levels in haemodialysis patients. 259
A new mathematical model for profiled-HFR 253
A case of Paget's disease in hemodialysis. 239
Combined application of Hemodiafiltration and Profiler: short and mid-term clinical results in 16 patients. 228
PTFE Grafts Versus Tunneled Cuffed Catheters for Hemodialysis: Which Is the Second Choice When Arteriovenous Fistula Is Not Feasible? 226
Donor/recipient delta age: A possible risk for arterial stenosis in renal transplantation 223
Anti-neutrophil cytoplasmic autoantibody-associated vasculitis in the very elderly: a 90-year-old iron lady. 222
Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters (TCC) thrombosis. 221
Is chronic kidney disease-mineral and bone disorder associated with the presence of endothelial progenitor cells with a calcifying phenotype? 218
Methylenetetrahydrofolate reductase, MTHFR, polymorphisms and predisposition to different multifactorial disorders 217
Comparison of Two Parathyroid Hormone Assays in Hemodialysis Patients 214
Coronary Calcifications in End-Stage Renal Disease Patients: A New Link between Osteoprotegerin, Diabetes and Body Mass Index? 211
Hypoacusia and chronic renal dysfunction: new etiopathogenetic prospective. 208
Impiego clinico del “Fegato Artificiale” MARS: effetti sulle citochine e sui fattori di crescita 203
Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients 201
Warfarin anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters thrombosis. 198
Clinical application of artificial liver support with the Molecular Adsorbent Recirculating System (MARS): impact on cytokines and growth factors 196
Thrombosis of Tunneled-Cuffed Hemodialysis Catheters: Treatment With High-Dose Urokinase Lock Therapy. 195
Un nuovo modello matematico per la HFR profilata 191
Eparina non frazionata vs eparina a basso peso molecolare: effetti sui livelli plasmatici di osteoprotegerina, RANKL e citochine infiammatorie in dialisi 191
EPC number and function is improved by VDRA treatment in hemodialysis patients 189
Emerging drugs for chronic kidney disease 187
Impiego combinato HFR-Profiler: risultati clinici a breve-medio termine 186
Effect of Vitamin D Receptor Activator Therapy on Vitamin D Receptor and Osteocalcin Expression in Circulating Endothelial Progenitor Cells of Hemodialysis Patients. 185
The cardiovascular burden of end-stage renal disease patients. 185
Effect of membrane permeability on survival of hemodialysis patients. 181
Functional Abnormalities and Thyroid Nodules in Patients with End-stage Renal Disease 181
Prevenzione della trombosi dei cateteri a permanenza per emodialisi: profilassi mediante anticoagulazione con warfarin 179
Polimorfismo del Vascular Endothelial Growth Factor e rischio cardiovascolare dopo trapianto renale 179
Folic Acid and Homocysteine in Chronic Kidney Disease and Cardiovascular Disease Progression: Which Comes First? 178
Fibroblast Growth Factor 23: Mineral Metabolism and beyond 169
Post-coronarography application of continuous veno-venous hemofiltration in the prevention of contrast nephropathy in patients with complex multisystem deficiency. 168
Fattori di rischio genetici per la patologia cardiovascolare dopo trapianto di rene: ruolo dei polimorfismi delle citochine 162
Jugular vein-mammary artery fistula after catheterism for hemodialysis: case report. 162
Metabolic syndrome after kidney transplantation. 162
Genetic variability and cardiovascular risk in renal transplant recipients 158
Restenosis in Hemodialytic Fistulas and Chronic Kidney Disease-Associated Vascular Disease: Two Pathologies Driven by Metakaryotic Stem Cells. 158
Effects of unfractioned heparin and low-molecular-weight heparin on osteoprotegerin and RANKL plasma levels in hemodialysis patients 155
Hemodiafiltration reduces mortality and prevents comorbidities? Technical innovations to improve hemodynamics and efficacy. [L'emodiafiltrazione riduce la mortalita' e previene le comorbidita'? Innovazioni tecniche per migliorare emodinamica ed efficacia.] 155
VDR Expression on Circulating Endothelial Progenitor Cells in Dialysis Patients Is Modulated by 25(OH)D Serum Levels and Calcitriol Therapy. 154
Factors determining cardiovascular disease progression after kidney transplant 154
Tyrosine-Kinase Inhibitors for Treatment in Hemodialysis Patients on Kidney Transplant Waiting List. Comment on: Nakai et al 152
MARS EFFICIENCY IN 38 PATIENTS WITH LIVER FAILURE 152
L’espressione del VDR sui progenitori delle cellule endoteliali è modulata dai livelli sierici di vitamina D 25(OH) e dalla terapia con calcitriolo nei pazienti in dialisi 150
Neutrophil Gelatinase-Associated Lipocalin as a Biomarker of Allograft Function After Renal Transplantation: Evaluation of the Current Status and Future Insights 144
EXTRACORPOREAL DETOXIFICATION FOR HEPATIC FAILURE WITH MARS: DEPURATIVE EFFICIENCY AND CLINICAL RESULTS IN 38 PATIENTS 143
Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology 142
Is beta2-microglobulin-related amyloidosis of hemodialysis patients a multifactorial disease? A new pathogenetic approach 134
Vitamin D-FGF-23 axis in kidney transplant recipients 134
Klotho-FGF23, cardiovascular disease, and vascular calcification: black or white? 131
Role of the hemodialysis vascular access type in inflammation status and monocyte activation. 129
Importance of vascular calcification in kidney transplant recipients 127
Protonic pump inhibitors in kidney transplant patients: efficacy and safety 124
Vitamin D in Kidney Transplant Recipients: Mechanisms and Therapy 108
null 88
null 75
null 73
Totale 11.929
Categoria #
all - tutte 29.637
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.637


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.234 0 67 85 100 134 81 42 85 61 97 266 216
2022/20231.507 129 252 72 212 82 118 30 75 288 40 141 68
2023/2024436 35 49 30 70 36 87 16 25 17 26 20 25
2024/20251.748 79 216 123 100 245 131 178 107 80 120 66 303
2025/20263.286 272 192 230 181 422 228 358 143 784 273 102 101
2026/2027149 64 85 0 0 0 0 0 0 0 0 0 0
Totale 11.929